Cargando…
Combined aliskiren and L-arginine treatment has antihypertensive effects and prevents vascular endothelial dysfunction in a model of renovascular hypertension
Angiotensin II is a key player in the pathogenesis of renovascular hypertension, a condition associated with endothelial dysfunction. We investigated aliskiren (ALSK) and L-arginine treatment both alone and in combination on blood pressure (BP), and vascular reactivity in aortic rings. Hypertension...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Associação Brasileira de Divulgação Científica
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4288495/ https://www.ncbi.nlm.nih.gov/pubmed/25493385 http://dx.doi.org/10.1590/1414-431X20144191 |
_version_ | 1782351981991428096 |
---|---|
author | Santuzzi, C.H. Tiradentes, R.V. Mengal, V. Claudio, E.R.G. Mauad, H. Gouvea, S.A. Abreu, G.R. |
author_facet | Santuzzi, C.H. Tiradentes, R.V. Mengal, V. Claudio, E.R.G. Mauad, H. Gouvea, S.A. Abreu, G.R. |
author_sort | Santuzzi, C.H. |
collection | PubMed |
description | Angiotensin II is a key player in the pathogenesis of renovascular hypertension, a condition associated with endothelial dysfunction. We investigated aliskiren (ALSK) and L-arginine treatment both alone and in combination on blood pressure (BP), and vascular reactivity in aortic rings. Hypertension was induced in 40 male Wistar rats by clipping the left renal artery. Animals were divided into Sham, 2-kidney, 1-clip (2K1C) hypertension, 2K1C+ALSK (ALSK), 2K1C+L-arginine (L-arg), and 2K1C+ALSK+L-arginine (ALSK+L-arg) treatment groups. For 4 weeks, BP was monitored and endothelium-dependent and independent vasoconstriction and relaxation were assessed in aortic rings. ALSK+L-arg reduced BP and the contractile response to phenylephrine and improved acetylcholine relaxation. Endothelium removal and incubation with N-nitro-L-arginine methyl ester (L-NAME) increased the response to phenylephrine in all groups, but the effect was greater in the ALSK+L-arg group. Losartan reduced the contractile response in all groups, apocynin reduced the contractile response in the 2K1C, ALSK and ALSK+L-arg groups, and incubation with superoxide dismutase reduced the phenylephrine response in the 2K1C and ALSK groups. eNOS expression increased in the 2K1C and L-arg groups, and iNOS was increased significantly only in the 2K1C group compared with other groups. AT(1) expression increased in the 2K1C compared with the Sham, ALSK and ALSK+L-arg groups, AT(2) expression increased in the ALSK+L-arg group compared with the Sham and L-arg groups, and gp91phox decreased in the ALSK+L-arg group compared with the 2K1C and ALSK groups. In conclusion, combined ALSK+L-arg was effective in reducing BP and preventing endothelial dysfunction in aortic rings of 2K1C hypertensive rats. The responsible mechanisms appear to be related to the modulation of the local renin-angiotensin system, which is associated with a reduction in endothelial oxidative stress. |
format | Online Article Text |
id | pubmed-4288495 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | Associação Brasileira de Divulgação Científica |
record_format | MEDLINE/PubMed |
spelling | pubmed-42884952015-01-21 Combined aliskiren and L-arginine treatment has antihypertensive effects and prevents vascular endothelial dysfunction in a model of renovascular hypertension Santuzzi, C.H. Tiradentes, R.V. Mengal, V. Claudio, E.R.G. Mauad, H. Gouvea, S.A. Abreu, G.R. Braz J Med Biol Res Biomedical Sciences Angiotensin II is a key player in the pathogenesis of renovascular hypertension, a condition associated with endothelial dysfunction. We investigated aliskiren (ALSK) and L-arginine treatment both alone and in combination on blood pressure (BP), and vascular reactivity in aortic rings. Hypertension was induced in 40 male Wistar rats by clipping the left renal artery. Animals were divided into Sham, 2-kidney, 1-clip (2K1C) hypertension, 2K1C+ALSK (ALSK), 2K1C+L-arginine (L-arg), and 2K1C+ALSK+L-arginine (ALSK+L-arg) treatment groups. For 4 weeks, BP was monitored and endothelium-dependent and independent vasoconstriction and relaxation were assessed in aortic rings. ALSK+L-arg reduced BP and the contractile response to phenylephrine and improved acetylcholine relaxation. Endothelium removal and incubation with N-nitro-L-arginine methyl ester (L-NAME) increased the response to phenylephrine in all groups, but the effect was greater in the ALSK+L-arg group. Losartan reduced the contractile response in all groups, apocynin reduced the contractile response in the 2K1C, ALSK and ALSK+L-arg groups, and incubation with superoxide dismutase reduced the phenylephrine response in the 2K1C and ALSK groups. eNOS expression increased in the 2K1C and L-arg groups, and iNOS was increased significantly only in the 2K1C group compared with other groups. AT(1) expression increased in the 2K1C compared with the Sham, ALSK and ALSK+L-arg groups, AT(2) expression increased in the ALSK+L-arg group compared with the Sham and L-arg groups, and gp91phox decreased in the ALSK+L-arg group compared with the 2K1C and ALSK groups. In conclusion, combined ALSK+L-arg was effective in reducing BP and preventing endothelial dysfunction in aortic rings of 2K1C hypertensive rats. The responsible mechanisms appear to be related to the modulation of the local renin-angiotensin system, which is associated with a reduction in endothelial oxidative stress. Associação Brasileira de Divulgação Científica 2014-10-24 /pmc/articles/PMC4288495/ /pubmed/25493385 http://dx.doi.org/10.1590/1414-431X20144191 Text en http://creativecommons.org/licenses/by-nc/3.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License, which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Biomedical Sciences Santuzzi, C.H. Tiradentes, R.V. Mengal, V. Claudio, E.R.G. Mauad, H. Gouvea, S.A. Abreu, G.R. Combined aliskiren and L-arginine treatment has antihypertensive effects and prevents vascular endothelial dysfunction in a model of renovascular hypertension |
title | Combined aliskiren and L-arginine treatment has antihypertensive effects
and prevents vascular endothelial dysfunction in a model of renovascular
hypertension |
title_full | Combined aliskiren and L-arginine treatment has antihypertensive effects
and prevents vascular endothelial dysfunction in a model of renovascular
hypertension |
title_fullStr | Combined aliskiren and L-arginine treatment has antihypertensive effects
and prevents vascular endothelial dysfunction in a model of renovascular
hypertension |
title_full_unstemmed | Combined aliskiren and L-arginine treatment has antihypertensive effects
and prevents vascular endothelial dysfunction in a model of renovascular
hypertension |
title_short | Combined aliskiren and L-arginine treatment has antihypertensive effects
and prevents vascular endothelial dysfunction in a model of renovascular
hypertension |
title_sort | combined aliskiren and l-arginine treatment has antihypertensive effects
and prevents vascular endothelial dysfunction in a model of renovascular
hypertension |
topic | Biomedical Sciences |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4288495/ https://www.ncbi.nlm.nih.gov/pubmed/25493385 http://dx.doi.org/10.1590/1414-431X20144191 |
work_keys_str_mv | AT santuzzich combinedaliskirenandlargininetreatmenthasantihypertensiveeffectsandpreventsvascularendothelialdysfunctioninamodelofrenovascularhypertension AT tiradentesrv combinedaliskirenandlargininetreatmenthasantihypertensiveeffectsandpreventsvascularendothelialdysfunctioninamodelofrenovascularhypertension AT mengalv combinedaliskirenandlargininetreatmenthasantihypertensiveeffectsandpreventsvascularendothelialdysfunctioninamodelofrenovascularhypertension AT claudioerg combinedaliskirenandlargininetreatmenthasantihypertensiveeffectsandpreventsvascularendothelialdysfunctioninamodelofrenovascularhypertension AT mauadh combinedaliskirenandlargininetreatmenthasantihypertensiveeffectsandpreventsvascularendothelialdysfunctioninamodelofrenovascularhypertension AT gouveasa combinedaliskirenandlargininetreatmenthasantihypertensiveeffectsandpreventsvascularendothelialdysfunctioninamodelofrenovascularhypertension AT abreugr combinedaliskirenandlargininetreatmenthasantihypertensiveeffectsandpreventsvascularendothelialdysfunctioninamodelofrenovascularhypertension |